/DXBRF

DXBRF Stock - BellRock Brands Inc.

Q: What is the analyst price target for DXBRF?

Analyst price target information is not currently available for DXBRF.

Q: What is DXBRF's market cap?

Market capitalization information is not currently available for DXBRF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DXBRF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2016

FY2017

FY2018

FY2019

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-134.88

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2019	FY2018	FY2017	FY2016
Revenue	$11.10M	$5.79M	$3.34M	$2.38M
Gross Profit	$4.02M	$2.82M	$1.32M	$528,239
Gross Margin	36.2%	48.7%	39.6%	22.2%
Operating Income	$-18,680,340	$-13,109,857	$-2,758,280	$-3,461,790
Net Income	$-20,140,089	$-20,293,058	$-4,040,035	$-4,027,121
Net Margin	-181.5%	-350.4%	-121.0%	-169.3%
EPS	$-0.16	$-0.35	$-0.03	$-0.03

Company Overview

BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans and pets. Its brands include Mary's Medicinals, Mary's Nutritionals, Mary's Methods, Mary's Tails, Beezle, Dixie, Synergy, Mindset, Aceso, Therabis, Défoncé, and Rebel Coast. The company was formerly known as Dixie Brands Inc. and changed its name to BellRock Brands Inc. in October 2020. BellRock Brands Inc. is headquartered in Denver, Colorado. As of October 10, 2022, BellRock Brands Inc. operates as a subsidiary of West 4th Holdings, LLC.

Visit Website

Frequently Asked Questions about DXBRF

What is DXBRF's current stock price?

BellRock Brands Inc. (DXBRF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for DXBRF?

No analyst price targets are currently available for this stock.

What sector is BellRock Brands Inc. in?

BellRock Brands Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is DXBRF's market cap?

BellRock Brands Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does DXBRF pay dividends?

No, BellRock Brands Inc. does not currently pay a dividend to shareholders.